EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Factor IXa and factor X influence factor VIIIa stability and inactivation mechanisms in vitro and in vivo

Johnathan J Morris iD, Nicole A Parsons iD, Amelia R Wilhelm iD, Robert J Davidson, Lauren K Olenick iD, Connor T Watson iD, Andrew Vanden Heuvel, Lindsey A George

Blood · 30.10.2025 · 146 (18) · 2259-2271

DOI: 10.1182/blood.2024027705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, erschienen am 30.10.2025. Verfasst von Johnathan J Morris und 7 weiteren Autor:innen. Beteiligte Einrichtung: Perelman Center for Cellular and Molecular Therapeutics and Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA. Hauptthemen laut MEDLINE: Factor VIIIa, Hemophilia A, Factor IXa, Factor X. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deficiency of factor VIII (FVIII) causes hemophilia A (HA), and excess FVIII function increases venous thromboembolic risk. The phenotypic consequences of aberrant FVIII function underscore the importance of understanding mechanisms that downregulate activated FVIII (FVIIIa) to inform disease pathology and therapeutic drug design. Spontaneous A2-domain dissociation and activated protein C (APC) proteolysis are established mechanisms of FVIIIa inactivation. However, we know very little about how FVIIIa binding interactions with FIXa and FX affect FVIIIa inactivation in vivo. Here, we investigate this using recombinant FVIIIa variants to probe A2-domain dissociation (FVIIIa-D519V,E665V) and APC cleavage (FVIIIa-R336Q,R562Q), or both (FVIIIa-R336Q,R562Q/D519V,E665V), in biochemical assays and in HA mouse injury models. We found that FIXa binding to FVIIIa stabilized the A2 domain and increased the contribution of APC to FVIIIa inactivation. Additional studies using individual APC cleavage site variants (FVIIIa-R336Q and FVIIIa-R562Q) demonstrated that FIXa and FX can protect FVIIIa from APC cleavage at Arg562 and Arg336, respectively, in a manner that is incomplete in vivo. Data also demonstrate that APC inactivation of FVIIIa exceeds FVIII, suggesting differential APC recognition of FVIIIa relative to FVIII. Hemostatic studies of FVIII variants with altered inactivation demonstrated that both A2-domain dissociation and APC cleavage contribute to in vivo FVIIIa regulation. Specifically, stabilizing the A2 domain, inhibiting APC cleavage, or both, improved potency 2.4-, 4.8-, and >10-fold, respectively, over wild-type FVIII in a mouse hemostatic assay. Data support that both mechanisms of FVIIIa inactivation and FIXa interactions could be leveraged to enhance FVIII function for therapeutic benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor VIIIaHemophilia AFactor IXaFactor XAnimalsHumansMiceProtein StabilityProtein CFactor VIIIProteolysisProtein BindingProtein Domains

Substanzen

Factor VIIIaFactor IXaFactor XProtein CFactor VIII

Autor:innen und Institutionen

  • Perelman Center for Cellular and Molecular Therapeutics and Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

ORCID-Profile: Johnathan J Morris, Nicole A Parsons, Amelia R Wilhelm, Lauren K Olenick, Connor T Watson

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Morris, J. J., Parsons, N. A., Wilhelm, A. R., Davidson, R. J., Olenick, L. K., Watson, C. T., Vanden Heuvel, A., & George, L. A. (2025). Factor IXa and factor X influence factor VIIIa stability and inactivation mechanisms in vitro and in vivo. Blood, 146(18), 2259-2271. https://doi.org/10.1182/blood.2024027705

Vancouver

Morris JJ, Parsons NA, Wilhelm AR, Davidson RJ, Olenick LK, Watson CT, et al. Factor IXa and factor X influence factor VIIIa stability and inactivation mechanisms in vitro and in vivo. Blood. 2025;146(18):2259-2271. doi:10.1182/blood.2024027705

BibTeX
@article{Morris2025,
  author = {Morris, Johnathan J and Parsons, Nicole A and Wilhelm, Amelia R and Davidson, Robert J and Olenick, Lauren K and Watson, Connor T and Vanden Heuvel, Andrew and George, Lindsey A},
  title = {Factor IXa and factor X influence factor VIIIa stability and inactivation mechanisms in vitro and in vivo},
  journal = {Blood},
  year = {2025},
  volume = {146},
  number = {18},
  pages = {2259--2271},
  doi = {10.1182/blood.2024027705}
}
Kostenlos starten →